3.595USD+9.44%Mkt Cap: 348.58M USDP/E: —Last update: 2026-06-01
Rezolute, Inc., a late-stage rare disease company, focused on improving outcomes for individuals with hypoglycemia caused by hyperinsulinism in the United States. Its lead clinical asset is ersodetug, an intravenously ad…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap348.58M USD
Enterprise Value199.57M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-74.41M USD
Revenue/Share—
Last Price3.595 USD
Fiscal Year EndJun 2025
MR QuarterMar 2026
Employees68
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-5.22
PEG—
EV/EBITDA-2.33
EV/Revenue—
P/S—
P/B2.67
EPS (TTM)-0.81
EPS (Forward)-0.63
52W Range
1.07024% of range11.46
52W High11.46 USD
52W Low1.070 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-45.90%
ROA-42.40%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-69.08M USD
CapEx (TTM)—
FCF Margin—
FCF Yield-12.54%
Net Debt-119.16M USD
Net Debt/EBITDA1.39
Balance Sheet
Debt/Equity0.01
Current Ratio15.84
Quick Ratio15.61
Book Value/Sh1.234 USD
Cash/Share1.249 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateOct 13, 2020
Splits
Last Split1:50
Split DateOct 13, 2020
Analyst Consensus
Rating1.7 (Buy)
Target (Mean)5.875 USD
Target Range4.000 USD – 10.00 USD
# Analysts8
Ownership
Shares Out.96.29M
Float66.03M
Insiders10.18%
Institutions90.35%
Short Interest
Short Ratio10.9d
Short % Float22.80%
Short % Out.15.15%
Shares Short14.58M
Short (prev mo.)12.87M
Technical
SMA 503.218 (+11.7%)
SMA 2005.399 (-33.4%)
Beta0.67
S&P 52W Chg27.70%
Avg Vol (30d)1.27M
Avg Vol (10d)1.09M
Technical Indicators
RSI (14)51.5
MACD0.0097
MACD Signal0.0075
MACD Hist.+0.0022
BB Upper3.419 USD
BB Middle3.256 USD
BB Lower3.092 USD
BB Width10.03%
ATR (14)0.2074 USD
Vol Ratio (20d)0.97x